Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendriks

Showing results (271-280 of 344) with videos related to

Pageof 35
Sort By:
Cancers|June 10, 2023
The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung CancerHaiyan Zeng, Fariba Tohidinezhad, Dirk K M De Ruysscher, et al.
Biomedical Chromatography : BMC|March 20, 2023
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasmaJudith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz, et al.
European Heart Journal|January 18, 2018
Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysisRajiv Mahajan, Tharani Perera, Adrian D Elliott, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic diseaseAntonin Levy, Lizza E L Hendriks, Thierry Berghmans, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2019
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitorsLizza E L Hendriks, Gerben Bootsma, Jean Mourlanette, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Cancer Letters|January 8, 2026
Automated CT-derived Body Composition Predicts Pathologic Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerYilong Huang, Zhitao Wei, Guanchao Ye, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2018
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF studyMelissa E Middeldorp, Rajeev K Pathak, Megan Meredith, et al.
Pageof 35

Showing results (271-280 of 344) with videos related to

Sort By:
Pageof 35
Cancers|June 10, 2023
The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung CancerHaiyan Zeng, Fariba Tohidinezhad, Dirk K M De Ruysscher, et al.
Biomedical Chromatography : BMC|March 20, 2023
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasmaJudith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz, et al.
European Heart Journal|January 18, 2018
Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysisRajiv Mahajan, Tharani Perera, Adrian D Elliott, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic diseaseAntonin Levy, Lizza E L Hendriks, Thierry Berghmans, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2019
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitorsLizza E L Hendriks, Gerben Bootsma, Jean Mourlanette, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Cancer Letters|January 8, 2026
Automated CT-derived Body Composition Predicts Pathologic Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerYilong Huang, Zhitao Wei, Guanchao Ye, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2018
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF studyMelissa E Middeldorp, Rajeev K Pathak, Megan Meredith, et al.
Pageof 35